Risk-Adapted Approach to clinical trials and Risk Assessments

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Health And Social Care

Published

January 28, 2022

Last updated

January 28, 2022

Description

The MHRA have implemented a dual strategy for a risk-adapted approach to clinical trials in the UK.

Organization

Country / Region

United Kingdom

License

Open Government Licence 2.0 (United Kingdom)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed